2World Health Organization. How to investigate drug use in health facilities : selected drug use indicators[R]. World Health Organization, 1993:1-92.
3Karen B, Nick F. Lessons from international experience in controlling pharmaceutical expenditure Ⅱ:Influencing doctors. Bri Med J, 1996, 312(7045 ) : 1525.
4Higgins JP, Thompson SG, Deeks J J, et al. Measuring on inconsisten- cy in meta analyses. BMJ Clinical Research Ed,2003,327 (7414) :557.
5DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials, 1986,7 (3) : 177.
6陈钟鸣.基本药物制度下山东省乡镇卫生院门诊用药情况研究-以某市为例.潍坊,潍坊医学院,2013.
7Okunade AA, Suraratdecha C. The Pervasiveness of Pharmaceutical Expenditure Inertia in the OECD Countries. Social Science & Medi- cine. 2006,63( 1 ) :225-238.
8WHO/HAI. Medicine prices: a new approach to measurement. Gene- va, World Health Organization. 2003. http ://haiweb. org/medicine- prices/.
